Understand the 2025

Key Takeaways The 2025 -26 influenza vaccine composition was determined by an internal panel, differing from previous years' external expert involvement. The primary update for the 2025 -26 vaccine is the inclusion of a new influenza A/H2N2 strain, while maintaining a trivalent formulation. The 2024-25 influenza season had high activity, with 94.7% of cases due to influenza A, and varying ...

Today, the FDA made recommendations to vaccine manufacturers for the virus strains to be used in the trivalent (three strain) flu vaccines for the 2025-2026 U.S. flu season following a thorough ...
Key Details About Understand The 2025 2026 Flu Vaccine Composition Recommendations

In September 2024, the FDA approved FluMist, the live attenuated influenza vaccine , for self- or caregiver administration. On March 13, 2025 , the U.S. Food and Drug Administration (FDA) made recommendations to update the composition of 2025-2026 U.S. influenza vaccines .
The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day meeting on the Composition of Influenza Virus Vaccines , a meeting that is held twice annually.

WHO Releases 2025
Today, the World Health Organization (WHO) announced its recommendations for the viral composition of influenza vaccines for the 2025-2026 season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day meeting on the Composition of Influenza Virus Vaccines , a meeting that is held 2 times per year. 1 WHO organizes these consultations with an ...
The FDA has issued updated strain composition recommendations for the 2025-2026 influenza season based on comprehensive US and global surveillance data. These recommendations , developed in collaboration with the CDC and DoD, maintain the trivalent formulation while updating the influenza A/H3N2 virus strain component from the previous season's formula.

FDA Makes Recommendations for 2025
Recommendations on the strain composition of influenza virus vaccines for the 2025-2026 US season have been issued by the Food and Drug Administration (FDA). The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.
Summary What is already known about this topic? Influenza vaccination protects against influenza and its potential complications. The Advisory Committee on Immunization Practices makes influenza vaccination recommendations for each influenza season. What is added by this report? Information for the 2025 -26 influenza season includes the updated vaccine composition , approval of FluMist (nasal ...

CDC Publishes 2025
The Centers for Disease Prevention and Control recently released the 2025-2026 influenza vaccine recommendations in its Morbidity and Mortality Week Report (MMWR) . Routine annual influenza vaccination is recommended for all persons aged ≥6 months wi...





The ACIP recommends seasonal flu vaccination with single-dose formulations that are free of thimerosal as a preservative for children, pregnant, women, and adults for the 2025-2026 flu season.